Kidney Cancer, Version 3.2015

Restricted access

The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These NCCN Guidelines Insights highlight the recent updates/changes in these guidelines, and updates include axitinib as first-line treatment option for patients with clear cell renal carcinoma, new data to support pazopanib as subsequent therapy for patients with clear cell carcinoma after first-line treatment with another tyrosine kinase inhibitor, and guidelines for follow-up of patients with renal cell carcinoma.

Provided content development and/or authorship assistance.

Supplementary Materials

    • Supplemental Material (PDF 180 KB)
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 502 502 35
PDF Downloads 86 86 12
EPUB Downloads 0 0 0